Dishman Carbogen Amcis Limited Return on Equity

Dishman Carbogen Amcis Limited (DCAL.NS) currently reports a ROE of 1.02%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Dishman Carbogen Amcis Limited's ROE history and peer comparisons.

Dishman Carbogen Amcis Limited's ROE of 1.02% is higher than the Healthcare sector average of -75.84%. That is roughly 101.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Dishman Carbogen Amcis Limited's current 1.02% should be judged against Healthcare norms (sector average: -75.84%) and against DCAL.NS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 1.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Dishman Carbogen Amcis Limited, and consider following DCAL.NS for alerts when major investors trade the stock.

Dishman Carbogen Amcis Limited is classified in the Healthcare sector. On ROE, it currently shows 1.02% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DCAL.NS with unrelated industries.